Pricing Log in Create free account
Tuesday 20 October 2026 Export INCY’s income statement to Excel — free account

Incyte Corporation

INCY Healthcare Biotechnology

Incyte Corporation’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, up 21.2% from fiscal 2024. In the quarter to June 2026, revenue grew 37.7%, EPS grew 39.7%, free cash flow grew 1,829.5% and total debt fell 10.5%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years.

113.25 0.18 +0.16%
Market cap
$23.0B
P/E
13.9×
Fwd P/E
58.4×
Dividend yield
—
F-score
9/9
Altman Z
8.57
Beneish M
−2.43
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Incyte Corporation (INCY) Current ratio

Alert me on Current ratio

Incyte Corporation's current ratio at the end of the quarter to 30 June 2026 was 4.6×, up 1.3× from fiscal 2025 (3.3×). Over the past ten years it has ranged from 2.0× (fiscal 2024) to 5.0× (fiscal 2015); the current reading is higher than 18% of that period. That is in line with the Biotechnology industry median of 4.8× and above the Healthcare sector median of 3.0×.

Current ratio, annual

Embed this chart

Annual newest first

Period Current ratio Change
FY2025 3.3× 68.07%
FY2024 2.0× (47.32%)
FY2023 3.7× 5.88%
FY2022 3.5× (3.10%)
FY2021 3.7× (2.36%)
FY2020 3.7× (22.66%)
FY2019 4.8× 12.20%
FY2018 4.3× 7.48%
FY2017 4.0× 10.28%
FY2016 3.6× (27.50%)

Quarterly newest first

Period Current ratio Change
Jun 2026 4.6× 24.76%
Mar 2026 3.7× 11.04%
Dec 2025 3.3× 3.76%
Sep 2025 3.2× 12.13%
42 more quarters

Against its own ten years

Low 2.0× High 5.0×
Ten-year median 3.7×
Current reading's percentile 18

Current ratio against peers

Company Current ratio
ROIV Roivant Sciences Ltd. compare 16.7×
BNTX BioNTech SE Sponsored ADR compare 7.8×
INCY Incyte Corporation 4.6×
INSM Insmed, Inc. compare 3.7×
EXEL Exelixis, Inc. compare 3.5×
ALNY Alnylam Pharmaceuticals, Inc. compare 3.1×
ASND Ascendis Pharma A/S compare 3.0×
RPRX Royalty Pharma PLC compare 2.8×
GMAB Genmab A/S Sponsored ADR compare 2.5×
Biotechnology industry median 4.8×
Healthcare sector median 3.0×
Market median 1.6×

What Current ratio is

Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.

Current Assets (Total) ÷ Current Liabilities (Total)

The full definition of Current ratio →

More on INCY